Thursday | 8 January, 2009
Stories by: Dylan Bushell-Embling
- +
Go-ahead for LCT 21/10/2008 11:35:00
LCT receives govt approval to trial DiabeCell porcine islets in NZ - +
Invitrogen, AB postpone merger 16/10/2008 14:45:00
Share slump and tax issues delay vote on Invitrogen-AB merger - +
Medical device news 16/10/2008 14:35:00
ImpediMed, KarmelSonics, Nanosonics - +
CSL hopes for big profit 15/10/2008 14:30:00
CSL predicts strong FY09 despite market crisis - +
Genera’s low false negatives 15/10/2008 14:35:00
Genera's HPV test outperforms HC2 in pilot trials - +
Silent suppression for Antisense 15/10/2008 14:40:00
ATL1101 suppresses prostate tumour growth in animal models - +
ImClone licenses VEGFR antibody 14/10/2008 13:20:00
ImClone to develop Vegenics’ VEGFR-3 inhibitor as pre-clinical candidate - +
ChemGenex completes SPP 14/10/2008 14:10:00
ChemGenex raises $13m for late-stage R&D - +
SCS adds to iPS portfolio 08/10/2008 16:02:00
SCS licenses adult-to-stem cell conversion technology - +
More supply for AtCor 08/10/2008 15:53:00
AtCor wins supply contract for SphygmoCor - +
No shock for USCOM 08/10/2008 15:50:00
USCOM improves paediatric septic shock management
Additional Resources
Newsletter Subscription
Australian Life Scientist Member Login
Fujitsu Introduces First Netbook Series – Fujitsu M1010, the Comprehensive Solution for Work and Play. 2008-12-15 16:30:00+11
Kingston Technology Boosts DataTraveler 150 Capacity to 64GB 2008-12-09 15:30:00+11
IDC Says Asia/Pacific Excluding Japan IT Market Will Remain The Bright Spot... 2008-12-04 15:04:00+11
AOC Launches 18.5” Widescreen Green 16:9 LCD Monitor in Australia and New Zealand 2008-12-03 15:30:00+11
NComputing Appoints Country Manager for Australia, New Zealand, and South Pacific Islands 2008-12-03 00:43:00+11
Sponsored Links
Subscribe to Australian Life Scientist
Australian Life Scientist is Australia's leading magazine for the life sciences sector.
